{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:41:15Z","timestamp":1683074475566},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1994,9,1]],"date-time":"1994-09-01T00:00:00Z","timestamp":778377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1994,9]]},"DOI":"10.1007\/bf01525511","type":"journal-article","created":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T06:26:32Z","timestamp":1113891992000},"page":"323-331","source":"Crossref","is-referenced-by-count":2,"title":["Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon \u03b2 in hairy-cell leukemia patients"],"prefix":"10.1007","volume":"38","author":[{"given":"Anna Marina","family":"Liberati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Fizzotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Schippa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Adiuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Di Clemente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Palmisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Micozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Zuccaccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saverio","family":"Cinieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1200\/JCO.1989.7.1.75","volume":"7","author":"MAK Allison","year":"1989","unstructured":"Allison MAK, Jones SE, McGuffey P (1989) Phase II trial of outpatient interleukin-2 in malignant lymphoma chronic lymphocytic leukemia and solected solid tumors. J Clin Ontol 7: 75","journal-title":"J Clin Ontol"},{"key":"CR2","first-page":"159","volume-title":"Statistical methods in medical research","author":"P Armitage","year":"1971","unstructured":"Armitage P (1971) Regression and oorrelation. In: Statistical methods in medical research, 1st edn. Blackwell, Oxford, p 159","edition":"1st edn."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-230X(08)60912-4","volume":"35","author":"MC Berenbaum","year":"1981","unstructured":"Berenbaum MC (1981) Criteria for analyzing interactions between biologically active agents. Adv Cancer Res 35: 269","journal-title":"Adv Cancer Res"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.4049\/jimmunol.135.2.1145","volume":"135","author":"CG Brooks","year":"1985","unstructured":"Brooks CG, Holscher M, Urdal D (1985) Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen. J Immunol 135: 1145","journal-title":"J Immunol"},{"key":"CR5","first-page":"405","volume":"11","author":"JC Cawley","year":"1984","unstructured":"Cawley JC, Armitage RJ, Worman CP (1984) T cell subsets in hairy cell leukemia. Semin Oncol 11: 405","journal-title":"Semin Oncol"},{"key":"CR6","first-page":"351","volume":"5","author":"BP Chen","year":"1986","unstructured":"Chen BP, Sondel PM (1986) Cytotoxicity of autologous Epstein-Barr virus-transformed cells mediated by interleukin-2 dependent, long-term T cell cultures is augmented by ?, but not ?, recombinant interferon. J Biol Response Mod 5: 351","journal-title":"J Biol Response Mod"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1182\/blood.V70.5.1530.1530","volume":"70","author":"M Chilosi","year":"1987","unstructured":"Chilosi M, Semenzato G, Cetto G, Ambrosetti A, Fiore-Donati L, Perona G, Berton G, Lestani M, Scarpa A, Agostini C, Trentin L, Zambello R, Masciarelli M, Dazzi F, Vinante F, Caligaris-Cappio F, Pizza G (1987) Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia relationship with the effect of recombinant ? interferon therapy on clinical parameters and natural killer in vitro activity. Blood 70: 1530","journal-title":"Blood"},{"key":"CR8","first-page":"91","volume":"1","author":"M Chun","year":"1987","unstructured":"Chun M, Hoffmann MK (1987) Modulation of interferon-induced NK cells by interleukin 2 and cAMP. Lymphokine Res 1: 91","journal-title":"Lymphokine Res"},{"key":"CR9","first-page":"383","volume":"8","author":"S D'Atri","year":"1986","unstructured":"D'Atri S, Tentori L, Fuggetta MP, Marini S, Bonmassar E (1986) A miniaturized cell-mediated cytotoxicity assay with human effector mononuclear cells. Int J Tissue React 8: 383","journal-title":"Int J Tissue React"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.1980.tb03808.x","volume":"45","author":"FR Davey","year":"1980","unstructured":"Davey FR, Dock NL, Wolos JA (1980) Studies of lymphocyte proliferation in hairy cell leukaemia: activity in mixed lymphocyte reaction and responses to mitogens. Br J Haematol 45: 29","journal-title":"Br J Haematol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM198704093161509","volume":"316","author":"JR Durant","year":"1987","unstructured":"Durant JR (1987) Immunotherapy of cancer: the end of the beginning? N Engl J Med 316: 939","journal-title":"N Engl J Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01669422","volume":"30","author":"TJ Eberlein","year":"1989","unstructured":"Eberlein TJ, Rodrick ML, Massaro AF, Jung SE, Mannick JA, Schoof DD (1989) Immunomodulatory effects of systemic lowdose recombinant interleukin-2 and lymphokine-activated killer cells in humans. Cancer Immunol Immunother 30: 145","journal-title":"Cancer Immunol Immunother"},{"key":"CR13","first-page":"392","volume":"64","author":"R Foa","year":"1986","unstructured":"Foa R, Lauria F, Lusso P, Raspadori D, Fierro MT, Tazzari PL, Caudana L, Matera L (1986) Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia. Clin Exp Immunol 64: 392","journal-title":"Clin Exp Immunol"},{"key":"CR14","first-page":"377","volume":"1","author":"R Foa","year":"1987","unstructured":"Foa R, Pierro MT, Lusso P, Bonferroni M, Raspadori D, Buzzi M, Zinzani PL, Resegotti L, Lauria F (1987) Effect of ?-interferon on the immune system of patients with hairy cell leukemia. Leukemia 1: 377","journal-title":"Leukemia"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0002-9343(86)90705-9","volume":"80","author":"KA Foon","year":"1986","unstructured":"Foon KA, Maluish AE, Abrams PG, Wrightington S, Stevenson HC, Alarif A, Fer MF, Overton WR, Poole M, Schipper EA, Jaffe ES, Herberman RB (1986) Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Therapeutic and immunologic results. Am J Med 80: 351","journal-title":"Am J Med"},{"key":"CR16","first-page":"600","volume":"53","author":"RA Knight","year":"1983","unstructured":"Knight RA, Worman CP, Cawley JC (1983) Defective autologous and allogeneic mixed lymphocyte reactions in hairy cell leukaemia. Clin Exp Immunol 53: 600","journal-title":"Clin Exp Immunol"},{"key":"CR17","first-page":"3875","volume":"48","author":"RL Krigel","year":"1988","unstructured":"Krigel RL, Padavic-Shaller KA, Rudolph AR, Litwin S, Konrad M, Bradley EC, Comis RL (1988) A phase I study of recombinant interleukin 2 plus recombinant ?-interferon. Cancer Res 48: 3875","journal-title":"Cancer Res"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.4049\/jimmunol.126.6.2321","volume":"126","author":"K Kuribayashi","year":"1981","unstructured":"Kuribayashi K, Gillis S, Kern DE, Henney CS (1981) Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. J Immunol 126: 2321","journal-title":"J Immunol"},{"key":"CR19","first-page":"409","volume":"11","author":"F Lauria","year":"1984","unstructured":"Lauria F, Fo\u00e0 R, Matera L, Raspadori D, Tura S (1984) Membrane phenotype and functional behaviour of T lymphocytes in hairy cell leukemia (HCL). Semin Oncol 11: 409","journal-title":"Semin Oncol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/1097-0142(19870601)59:11<1906::AID-CNCR2820591111>3.0.CO;2-A","volume":"59","author":"AM Liberati","year":"1987","unstructured":"Liberati AM, Ballatori E, Fizzotti M, Schippa M, Proietti MG, Di Marzio R, Pecci A, Biscetti L, Sbarretti R, Cini L, Grignani F (1987) Immunologic profile in patients with Hodgkin's disease in complete remission. Cancer 59: 1906","journal-title":"Cancer"},{"key":"CR21","first-page":"375","volume":"76","author":"AM Liberati","year":"1991","unstructured":"Liberati AM, Schippa M, Portuesi MG, Proietti MG, De Angelis V, Ferrajoli A, Cinieri S, Di Clemente F, Palmisano L, Berruto P (1991) IFN? induced biochemical and immunological modifications in hairy cell leukemia patients. Haematologica 76: 375","journal-title":"Haematologica"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF01741345","volume":"34","author":"AM Liberati","year":"1991","unstructured":"Liberati AM, Horisberger M, Schippa M, Di Clemente F, Fizzotti M, Filippo S, Proietti MG, Arzano S, Berruto P, Palmisano L, Cinieri S (1991) Biochemical and immunological host responses of hairy cell leukemia patients to IFN?. Cancer Immunol Immunother 34: 115","journal-title":"Cancer Immunol Immunother"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0609.1989.tb00247.x","volume":"42","author":"B Nielsen","year":"1989","unstructured":"Nielsen B, Hokland M, Justesen J, Hasselbalch H, Ellegaard J, Hokland P (1989) Immunological recovery and dose evaluation in IFN-? treatment of hairy cell leukemia: analysis, of leukocyte differentiation antigens, NK and 2?, 5?-oligoadenylate synthetase activity. Eur J Haematol 42: 50","journal-title":"Eur J Haematol"},{"key":"CR24","first-page":"10","volume":"15","author":"DR Parkinson","year":"1988","unstructured":"Parkinson DR (1988) Interleukin-2 in cancer therapy. Semin Oncol 15: 10","journal-title":"Semin Oncol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2249.1991.tb05726.x","volume":"85","author":"RK Puri","year":"1991","unstructured":"Puri RK, Leland P (1991) In vivo treatment with interferon causes augmentation of IL-2 induced lymphokine-activated killer cells in the organs of mice. Clin Exp Immunol 85: 317","journal-title":"Clin Exp Immunol"},{"key":"CR26","first-page":"1628","volume":"16","author":"KM Ramsey","year":"1984","unstructured":"Ramsey KM, Dyer D, Stocks N, Djeu JY (1984) Enhancement of natural killer cell activity by interferon and interleukin-2 in human large granular lymphocytes inhibited by cyclosporine. Transplant Proc 16: 1628","journal-title":"Transplant Proc"},{"key":"CR27","first-page":"379","volume":"3","author":"MM Reddy","year":"1984","unstructured":"Reddy MM, Chinoy P, Grieco MH (1984) Differential effects of interferon-?2 and interleukin-2 on natural killer cell activity in patients with acquired immune deficiency syndrome. J Biol Response Mod 3: 379","journal-title":"J Biol Response Mod"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood.V73.5.1351.1351","volume":"73","author":"JE Reittie","year":"1989","unstructured":"Reittie JE, Gottlieb D, Heslop HE, Leger O, Drexler HG, Hazlehurst G, Hoffbrand AV, Prentice HG, Brenner MK (1989) Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy. Blood 73: 1351","journal-title":"Blood"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V61.6.1132.1132","volume":"61","author":"LP Ruco","year":"1983","unstructured":"Ruco LP, Procopio A, Maccallini V, Calogero A, Uccini S, Annino L, Mandelli F, Baroni CD (1983) Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 61: 1132","journal-title":"Blood"},{"key":"CR30","first-page":"336","volume":"42","author":"LJM Sabbe","year":"1980","unstructured":"Sabbe LJM, Meijer CJLM, Jansen J (1980) T lymphocyte function in hairy cell leukaemia. Clin Exp Immunol 42: 336","journal-title":"Clin Exp Immunol"},{"key":"CR31","unstructured":"SAS Institute Inc. (1993) Release 6.0. Cari publisher, NC, pp 1195?1210"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.V68.1.293.293","volume":"68","author":"G Semenzato","year":"1986","unstructured":"Semenzato G, Pizzolo G, Agostini C, Ambrosetti A, Zambello R, Trentin L, Luca M, Masciarelli M, Chilosi M, Vinante F, Perona G, Cetto G (1986) ?-Interferon activates the natural killer system in patients with hairy cell leukemia. Blood 68: 293","journal-title":"Blood"},{"key":"CR33","first-page":"529","volume":"9","author":"M Sznol","year":"1990","unstructured":"Sznol M, Mier JW, Sparano J, Gaynor ER, Weiss GR, Margolin KA, Bar MH, Hawkins MJ, Atkins MB, Dutcher JP (1990) A phase I study of high-dose interleukin-2 in combination with interferon-alpha 2b. J Biol Response Mod 9: 529","journal-title":"J Biol Response Mod"},{"key":"CR34","first-page":"730","volume":"49","author":"T Tamura","year":"1989","unstructured":"Tamura T, Sasaki Y, Shinkai T, Eguchi K, Sakurai M, Fujiwara Y, Nakagawa K, Minato K, Bungo M, Saijo N (1989) Phase I study of combination therapy with interleukin-2 and beta-interferon in patients with advanced malignancy. Cancer Res 49: 730","journal-title":"Cancer Res"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1200\/JCO.1988.6.4.669","volume":"6","author":"JA Thompson","year":"1988","unstructured":"Thompson JA, Lee DJ, Lindgren CG, Benz LA, Collins C, Levitt D, Fefer A (1988) Influence of dose and duration of infusion of inerleukin-2 on toxicity and immunomodulation. J Clin Oncol 6: 669","journal-title":"J Clin Oncol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.153.3.569","volume":"153","author":"T Timonen","year":"1981","unstructured":"Timonen T, Ortaldo JR, Herberman RB (1981) Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 153: 569","journal-title":"J Exp Med"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0145-2126(87)90069-5","volume":"11","author":"L Trentin","year":"1987","unstructured":"Trentin L, Ambrosetti A, Zambello R, Agostini C, Masciarelli M, Vinante F, Chilosi M, Pizzolo G, Cetto G, Semenzato G (1987) Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events. Leukemia Res 11: 843","journal-title":"Leukemia Res"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V75.7.1525.1525","volume":"75","author":"L Trentin","year":"1990","unstructured":"Trentin L, Zambello R, Agostini C, Ambrosetti A, Chisesi T, Raimondi R, Bulian P, Pizzolo G, Semenzato G (1990) Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia. Blood 75: 1525","journal-title":"Blood"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.4049\/jimmunol.136.5.1700","volume":"136","author":"RJ Griend Van De","year":"1986","unstructured":"Van De Griend RJ, Ronteltap CPM, Gravekamp C, Monnikendam D, Bolhuis RLH (1986) Interferon-? and recombinant IL-2 ean both enhance, but by different pathways, the nonspecific cytolytic potential of T3? natural killer cell-derived clones rather than that of T3+ clones. J Immunol 136: 1700","journal-title":"J Immunol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.130.2.768","volume":"130","author":"BM Vose","year":"1983","unstructured":"Vose BM, Riccardi C, Bonnard GD, Herberman RB (1983) Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. Regulatory role of interferon on proliferative and cytotoxic precursors. J Immunol 130: 768","journal-title":"J Immunol"},{"key":"CR41","first-page":"3910","volume":"51","author":"LM Weiner","year":"1991","unstructured":"Weiner LM, Padavic-Shaller K, Kitson J, Watts P, Kriegel RL, Litwin S (1991) Phase I evaluation of combination therapy with interleukin-2 and gamma interferon. Cancer Res 51: 3910","journal-title":"Cancer Res"},{"key":"CR42","first-page":"103","volume":"61","author":"JA Werkmeister","year":"1985","unstructured":"Werkmeister JA, Boyd AW, Triglia T, Burns GF (1985) Lymphocytes from patients with hairy cell leukaemia enable the distinction of two separate subpopulations of activated lymphocyte killer cells generated in mixed lymphocyte culture. Clin Exp Immunol 61: 103","journal-title":"Clin Exp Immunol"},{"key":"CR43","first-page":"3669","volume":"51","author":"SC Yang","year":"1991","unstructured":"Yang SC, Grimm EA, Parkinson DR, Carinhas J, Fry KD, Mendiguren-Rodriguez A, Licciardello J, Owen-Schaub LB, Hong WK, Roth JA (1991) Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial. Cancer Res 51: 3669","journal-title":"Cancer Res"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0268-960X(90)90044-S","volume":"4","author":"SL Zaknoen","year":"1990","unstructured":"Zaknoen SL, Kay NE (1990) Immunoregulatory cell dysfunction in chronic B-cell leukemias. Blood Rev 4: 165","journal-title":"Blood Rev"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ijc.2910270310","volume":"27","author":"HW Ziegler","year":"1981","unstructured":"Ziegler HW, Kay NE, Zarling JM (1981) Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia. Int J Cancer 27: 321","journal-title":"Int J Cancer"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01525511\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01525511.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01525511\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01525511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:23:25Z","timestamp":1683073405000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01525511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1994,9]]}},"alternative-id":["BF01525511"],"URL":"https:\/\/doi.org\/10.1007\/bf01525511","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,9]]}}}